Pamela U. Freda

10.0k total citations · 2 hit papers
103 papers, 5.7k citations indexed

About

Pamela U. Freda is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Pamela U. Freda has authored 103 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Pamela U. Freda's work include Pituitary Gland Disorders and Treatments (84 papers), Growth Hormone and Insulin-like Growth Factors (69 papers) and Adrenal and Paraganglionic Tumors (29 papers). Pamela U. Freda is often cited by papers focused on Pituitary Gland Disorders and Treatments (84 papers), Growth Hormone and Insulin-like Growth Factors (69 papers) and Adrenal and Paraganglionic Tumors (29 papers). Pamela U. Freda collaborates with scholars based in United States, Italy and United Kingdom. Pamela U. Freda's co-authors include Kalmon D. Post, Sharon L. Wardlaw, Jeffrey N. Bruce, Laurence Katznelson, Carlos M. Reyes, Wei Shen, Mark E. Molitch, Carlos Reyes-Vidal, Jardena J. Puder and Mary Lee Vance and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Applied Physiology and Journal of neurosurgery.

In The Last Decade

Pamela U. Freda

97 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

2014 302 citations Annamaria Colao, Marcello D. Bronstein et al. The Journal of Clinical Endocrinology & Metabolism profile →
A Pituitary Society update to acromegaly management guidelines

2020 192 citations Maria Fleseriu, Beverly M. K. Biller et al. Pituitary profile →

Peers

Pamela U. Freda

EDM

SURGE

EPIDE

GENET

Maura Arosio Italy

Stephan Petersenn Germany

Roger Abs Belgium

Pia Burman Sweden

Niki Karavitaki United Kingdom

John P. Monson United Kingdom

Eleonora P.M. Corssmit Netherlands

Francesco Minuto Italy

Salvatore Cannavò Italy

Maria Fleseriu United States

Maura Arosio Italy

Pamela U. Freda

4.7k ×1.0

EDM

2.1k ×1.1

SURGE

832 ×0.6

EPIDE

364 ×0.5

GENET

669 ×1.2

Citations per year, relative to Pamela U. Freda Pamela U. Freda (= 1×) peers Maura Arosio

Countries citing papers authored by Pamela U. Freda

Since Specialization

Citations

This map shows the geographic impact of Pamela U. Freda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela U. Freda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela U. Freda more than expected).

Fields of papers citing papers by Pamela U. Freda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela U. Freda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela U. Freda. The network helps show where Pamela U. Freda may publish in the future.

Co-authorship network of co-authors of Pamela U. Freda

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela U. Freda. A scholar is included among the top collaborators of Pamela U. Freda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela U. Freda. Pamela U. Freda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuen, Kevin C.J., Wenyu Huang, Maria Fleseriu, et al.. (2024). 9191 Real-world Biochemical And Symptoms Outcomes With Oral Octreotide: Management Of Acromegaly (MACRO) Registry Experience. Journal of the Endocrine Society. 8(Supplement_1).

Agarwal, Sanchita, Elizabeth Shane, Eliza B. Geer, et al.. (2024). Long-term Pegvisomant Therapy of Acromegaly: Effects on Bone Density, Turnover and Microstructure Using HRpQCT. Journal of the Endocrine Society. 8(6). bvae079–bvae079. 2 indexed citations

Sheppard, Michael C., Marcello D. Bronstein, Pamela U. Freda, et al.. (2014). Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study. Pituitary. 18(3). 385–394. 67 indexed citations

Freda, Pamela U., Murray B. Gordon, Nicky Kelepouris, et al.. (2014). Long-Term Treatment with Pegvisomant as Monotherapy in Patients with Acromegaly: Experience from Acrostudy. Endocrine Practice. 21(3). 264–274. 59 indexed citations

Colao, Annamaria, Marcello D. Bronstein, Pamela U. Freda, et al.. (2012). Pasireotide LAR is significantly more effective than octreotide LAR at inducing biochemical control in patients with acromegaly: results of a 12-month randomized, double-blind, multicenter, Phase III study. 15th International & 14th European Congress of Endocrinology. 29. 12 indexed citations

Fleseriu, Maria, M C Sheppard, Marcello D. Bronstein, et al.. (2012). Pasireotide LAR vs octreotide LAR in patients with acromegaly: double-blind, crossover, extension period to a randomized, double-blind, multicenter, phase III study. 15th International & 14th European Congress of Endocrinology. 29. 3 indexed citations

Freda, Pamela U., Albert Beckers, Laurence Katznelson, et al.. (2011). Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 96(4). 894–904. 356 indexed citations

Lund, Lars H., et al.. (2010). Leptin Resistance After Heart Transplantation. European Journal of Heart Failure. 12(5). 516–520. 6 indexed citations

Freda, Pamela U. & Jeffrey N. Bruce. (2010). Risks of pituitary surgery in the elderly. Nature Reviews Endocrinology. 6(11). 606–608. 14 indexed citations

10.

Lund, Lars H., Pamela U. Freda, & Donna Mancini. (2009). What is the Relationship Between Cardiac and Peripheral Ghrelin Production? Reply. European Journal of Heart Failure. 11(11). 1111–1111.

11.

Lund, Lars H., et al.. (2009). Ghrelin Resistance Occurs in Severe Heart Failure and Resolves After Heart Transplantation. European Journal of Heart Failure. 11(8). 789–794. 34 indexed citations

12.

Lund, Lars H., et al.. (2009). Growth Hormone Resistance in Severe Heart Failure Resolves After Cardiac Transplantation. European Journal of Heart Failure. 11(5). 525–528. 19 indexed citations

13.

Bidlingmaier, Martin & Pamela U. Freda. (2009). Measurement of human growth hormone by immunoassays: Current status, unsolved problems and clinical consequences. Growth Hormone & IGF Research. 20(1). 19–25. 88 indexed citations

14.

Boscaro, Marco, W.H. Ludlam, Brew Atkinson, et al.. (2008). Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial. The Journal of Clinical Endocrinology & Metabolism. 94(1). 115–122. 207 indexed citations

15.

Fairfield, Wesley P., Gemma Sesmilo, Laurence Katznelson, et al.. (2002). Effects of a growth hormone receptor antagonist on bone markers in acromegaly. Clinical Endocrinology. 57(3). 385–390. 30 indexed citations

16.

Klibanski, Anne, Ken K. Y. Ho, Pamela U. Freda, et al.. (2001). State-of-the-Art Strategies for the Diagnosis and Management of Acromegaly. The Endocrinologist. 11(3). 223–232. 4 indexed citations

17.

Rubin, Mishaela R., Jeffrey N. Bruce, Alexander G. Khandji, & Pamela U. Freda. (2001). Sarcoidosis within a Pituitary Adenoma. Pituitary. 4(3). 195–202. 16 indexed citations

18.

Freda, Pamela U., et al.. (2000). Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide. The Journal of Clinical Endocrinology & Metabolism. 85(1). 8–13. 38 indexed citations

19.

Freda, Pamela U. & Kalmon D. Post. (1999). DIFFERENTIAL DIAGNOSIS OF SELLAR MASSES. Endocrinology and Metabolism Clinics of North America. 28(1). 81–117. 236 indexed citations

20.

Freda, Pamela U., et al.. (1997). Spectrum of Adrenal Dysfunction in Patients with Acquired Immunodeficiency Syndrome. Trends in Endocrinology and Metabolism. 8(5). 173–180. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact